Navigation Links
LSUHSC's England plays key role in developing new ALS treatment guidelines
Date:10/12/2009

New Orleans, LA Dr. John England, Professor and Chairman of Neurology at LSU Health Sciences Center New Orleans, analyzed research findings and was responsible for the quality and accuracy of evidence analysis and the conclusions of the studies resulting in new guidelines for treating Lou Gehrig's disease, or amyotropic lateral sclerosis (ALS). The guidelines will be published in the October 13, 2009 issue of Neurology, the journal of the American Academy of Neurology.

The guidelines recommend the use of the drug riluzole, the only FDA-approved drug for ALS, to slow the progression of the disease. Assisted-breathing devices and the use of a PEG feeding tube may increase longevity and quality of life. Botulin toxin B may be used to treat drooling if oral medications are not effective. And the guidelines recommend screening patients for behavioral or thinking problems because they commonly occur with this disease and may interfere with treatment choices. Early enrollment in a multidisciplinary ALS clinic is advised because access to specialized treatments may also increase survival and quality of life.

"These new guidelines provide specific, evidence-based recommendations for the care of patients with ALS," notes Dr. England. "Although we do not yet have a cure for this disease, these guidelines identify several treatments that can help people with ALS live longer and better lives."

According to the National Institute of Neurological Disorders, ALS is a rapidly progressive, invariably fatal neurological disease that attacks the nerve cells responsible for controlling voluntary muscles. As many as 20,000 Americans have ALS, and an estimated 5,000 people in the United States are diagnosed with the disease each year. ALS is one of the most common neuromuscular diseases worldwide, and people of all races and ethnic backgrounds are affected. ALS most commonly strikes people between 40 and 60 years of age, but younger and older people can also develop the disease. Men are affected more often than women. In 90-95% if the cases, the disease occurs apparently at random with no clearly associated risk factors.


'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

Related biology news :

1. Films of Mitchell and Kenyon illuminate lefties decline in Victorian England
2. Mystery of infamous New England Dark Day solved by 3 rings
3. Mystery of infamous New England Dark Day solved by tree rings
4. UNH researchers tag first-ever free-swimming leatherback turtles in New England
5. Study: Illegal fishing harming present and future New England groundfish fisheries
6. Data published in the New England Journal of Medicine support use of raxibacumab (ABthrax) for the treatment of inhalation anthrax
7. Speed plays crucial role in breaking proteins H-bonds
8. Small RNA plays parallel roles in bacterial metabolism
9. Moss protein plays role in Alzheimers disease
10. Early parenting plays key role in infants physiological response to stress
11. Protein identified that plays role in blood flow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2017)... 16, 2017   Bridge Patient Portal , ... MD EMR Systems , an electronic medical ... GE, have established a partnership to build an ... the GE Centricity™ products, including Centricity Practice Solution ... These new integrations will allow healthcare delivery ...
(Date:4/18/2017)...  Socionext Inc., a global expert in SoC-based imaging and computing ... M820, which features the company,s hybrid codec technology. A demonstration utilizing ... Inc., will be showcased during the upcoming Medtec Japan at Tokyo ... Las Vegas Convention Center April 24-27. ... Click here for an image ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... New York, NY (PRWEB) , ... October 12, ... ... York Academy of Sciences today announced the three Winners and six Finalists of ... Awards are given annually by the Blavatnik Family Foundation and administered by the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the first-ever genomics analysis platform specifically designed for life science researchers to ... of pioneering researcher Rosalind Franklin, who made a major contribution to the ...
(Date:10/11/2017)... ... 11, 2017 , ... Proscia Inc ., a data ... titled, “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, ... and how Proscia improves lab economics and realizes an increase in diagnostic confidence.* ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced ... to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B ... to cross the cell membrane and bind intracellular STAT3 and inhibit its function. ...
Breaking Biology Technology: